Skip to navigation Skip to main content Skip to footer

Approved Research

Impact of SARS-CoV-2 on medication use in patients with chronic diseases

Principal Investigator: Miss Tong Li
Approved Research ID: 89099
Approval date: July 21st 2022
Central South University

Lay summary

Aim: To investigate changes in medication use before infection and after recovery from SARS-CoV-2 in patients with chronic disease.

Scientific rationale: Evidence suggests that a series of long COVID-19 symptoms may persist long after acute SARS-CoV-2 infection, such as fatigue, dyspnea, palpitations, joint pain and headache. In addition, some research studies have shown that some patients with chronic diseases had poor self-reported physical health after COVID-19. However, the impact of SARS-CoV-2 infection on medication use in chronic patients is still unclear. So this project aims to explore the changes in medication use before infection and after recovery from SARS-CoV-2 in patients with chronic disease.

Project duration: 36 months.

Public health impact: The project is expected to find differences in medication use before infection and after recovery from SARS-CoV-2 in patients with chronic diseases, contributing to increased understanding of the impact of SARS-CoV-2.

© UK Biobank Limited 2024 | Registered in England and Wales with company number 4978912.
Registered as a charity in England and Wales (number 1101332) and in Scotland (number SC039230).
Registered office Units 1-2 Spectrum Way, Stockport, Cheshire, SK3 0SA.